中国骨髓移植之父陆道培斩获国际医学大奖

2016-03-27 佚名 生物谷

24日,中国骨髓移植之父陆道培院士就荣获2016年国际血液与骨髓移植研究中心(CIBMTR)杰出服务贡献奖召开新闻发布会。据悉,他是迄今为止唯一获得此奖项的中国专家。 据介绍,1964年,陆道培完成亚洲第一例骨髓移植术,他采用双胞胎姐妹的骨髓,成功救治一位22岁身患重症再生障碍性贫血的患者。1981年,陆道培完成中国首例异基因半相合骨髓移植。美国CIBMTR执行委员会主席Dr.PaulJ.

24日,中国骨髓移植之父陆道培院士就荣获2016年国际血液与骨髓移植研究中心(CIBMTR)杰出服务贡献奖召开新闻发布会。据悉,他是迄今为止唯一获得此奖项的中国专家。

据介绍,1964年,陆道培完成亚洲第一例骨髓移植术,他采用双胞胎姐妹的骨髓,成功救治一位22岁身患重症再生障碍性贫血的患者。1981年,陆道培完成中国首例异基因半相合骨髓移植。美国CIBMTR执行委员会主席Dr.PaulJ.Martin教授提到,“80年代,我们在西雅图尝试做半相合骨髓移植,结果真是非常的糟糕。”另外,上世纪90年代,陆道培积极呼吁并参与筹建中华骨髓库。1997年,陆道培建立了中国首个国家批准的脐带血库,并于2000年首先成功开展成人双份脐带血移植。

在昨天的新闻发布会上,陆道培院士提到,目前,我们已实现骨髓造血干细胞的输送、移植,并建立了中华骨髓库。但移植后,有很多合并症需要预防和治疗,这是骨髓移植术面临的巨大挑战,现在正研究不通过移植术直接用药方式治疗各种血液病。

另据了解,今年85岁的陆道培仍在河北燕达陆道培医院进行门诊和查房工作。今年7月,位于北京亦庄开发区的北京陆道培医院将正式启用。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=76117, encodeId=0ac7e611712, content=陆道培院士是我们的楷模!, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160406/IMG570506F023DF05364.jpg, createdBy=f19f1695574, createdName=拯救我的未来, createdTime=Wed Apr 06 21:01:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76092, encodeId=8f65e6092e7, content=向老专家致敬!, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Wed Apr 06 19:35:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490098, encodeId=25e3149009809, content=<a href='/topic/show?id=8db298001d9' target=_blank style='color:#2F92EE;'>#陆道培#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98001, encryptionId=8db298001d9, topicName=陆道培)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b16f8693542, createdName=meichuangyi, createdTime=Tue Mar 29 00:17:00 CST 2016, time=2016-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74033, encodeId=9d7be403363, content=老专家, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Mar 27 23:16:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74001, encodeId=94f5e400123, content=学习的榜样, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Sun Mar 27 18:28:00 CST 2016, time=2016-03-27, status=1, ipAttribution=)]
    2016-04-06 拯救我的未来

    陆道培院士是我们的楷模!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=76117, encodeId=0ac7e611712, content=陆道培院士是我们的楷模!, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160406/IMG570506F023DF05364.jpg, createdBy=f19f1695574, createdName=拯救我的未来, createdTime=Wed Apr 06 21:01:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76092, encodeId=8f65e6092e7, content=向老专家致敬!, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Wed Apr 06 19:35:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490098, encodeId=25e3149009809, content=<a href='/topic/show?id=8db298001d9' target=_blank style='color:#2F92EE;'>#陆道培#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98001, encryptionId=8db298001d9, topicName=陆道培)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b16f8693542, createdName=meichuangyi, createdTime=Tue Mar 29 00:17:00 CST 2016, time=2016-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74033, encodeId=9d7be403363, content=老专家, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Mar 27 23:16:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74001, encodeId=94f5e400123, content=学习的榜样, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Sun Mar 27 18:28:00 CST 2016, time=2016-03-27, status=1, ipAttribution=)]
    2016-04-06 1de11f7fm56(暂无匿称)

    向老专家致敬!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=76117, encodeId=0ac7e611712, content=陆道培院士是我们的楷模!, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160406/IMG570506F023DF05364.jpg, createdBy=f19f1695574, createdName=拯救我的未来, createdTime=Wed Apr 06 21:01:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76092, encodeId=8f65e6092e7, content=向老专家致敬!, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Wed Apr 06 19:35:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490098, encodeId=25e3149009809, content=<a href='/topic/show?id=8db298001d9' target=_blank style='color:#2F92EE;'>#陆道培#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98001, encryptionId=8db298001d9, topicName=陆道培)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b16f8693542, createdName=meichuangyi, createdTime=Tue Mar 29 00:17:00 CST 2016, time=2016-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74033, encodeId=9d7be403363, content=老专家, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Mar 27 23:16:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74001, encodeId=94f5e400123, content=学习的榜样, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Sun Mar 27 18:28:00 CST 2016, time=2016-03-27, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=76117, encodeId=0ac7e611712, content=陆道培院士是我们的楷模!, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160406/IMG570506F023DF05364.jpg, createdBy=f19f1695574, createdName=拯救我的未来, createdTime=Wed Apr 06 21:01:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76092, encodeId=8f65e6092e7, content=向老专家致敬!, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Wed Apr 06 19:35:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490098, encodeId=25e3149009809, content=<a href='/topic/show?id=8db298001d9' target=_blank style='color:#2F92EE;'>#陆道培#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98001, encryptionId=8db298001d9, topicName=陆道培)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b16f8693542, createdName=meichuangyi, createdTime=Tue Mar 29 00:17:00 CST 2016, time=2016-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74033, encodeId=9d7be403363, content=老专家, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Mar 27 23:16:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74001, encodeId=94f5e400123, content=学习的榜样, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Sun Mar 27 18:28:00 CST 2016, time=2016-03-27, status=1, ipAttribution=)]
    2016-03-27 wei834766788

    老专家

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=76117, encodeId=0ac7e611712, content=陆道培院士是我们的楷模!, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160406/IMG570506F023DF05364.jpg, createdBy=f19f1695574, createdName=拯救我的未来, createdTime=Wed Apr 06 21:01:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76092, encodeId=8f65e6092e7, content=向老专家致敬!, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Wed Apr 06 19:35:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490098, encodeId=25e3149009809, content=<a href='/topic/show?id=8db298001d9' target=_blank style='color:#2F92EE;'>#陆道培#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98001, encryptionId=8db298001d9, topicName=陆道培)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b16f8693542, createdName=meichuangyi, createdTime=Tue Mar 29 00:17:00 CST 2016, time=2016-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74033, encodeId=9d7be403363, content=老专家, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Mar 27 23:16:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74001, encodeId=94f5e400123, content=学习的榜样, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Sun Mar 27 18:28:00 CST 2016, time=2016-03-27, status=1, ipAttribution=)]
    2016-03-27 老段

    学习的榜样

    0

相关资讯

NEJM:骨髓移植患者多数可找到供者

新英格兰医学杂志( New England Journal of Medicine)7 月 24 日在线发表的一项研究显示,在美国,需要骨髓移植的多数患者都可找到合适供体,但找到配型完全相合的可能性较低,其概率因种族而异。这项研究是由美国国家骨髓库(NMDP)Dennis Confer 博士负责。位于明尼苏达州明尼阿波利斯市的美国国家骨髓库建于 1986 年,目的是协助患者寻找合适供者。该组织建立

ONF:cGVHD患者临床表现、细胞因子水平和生活质量有何关联?

目的:该研究的目的是描述慢性移植物抗宿主病(cGVHD)患者的临床表现、细胞因子水平和生活质量。研究方式:该实验采用前瞻性、横断面、队列研究,我们通过采用查寻病史档案和问卷调查(问卷已经过认证)的方式收集了患者的人口统计学因素、临床表现和生活质量等相关资料,并通过患者血清测定分析其细胞因子水平。我们关注的主要指标是慢性移植物抗宿主病(cGVHD)患者的临床表现、细胞因子水平/C反应蛋白水平和患者的

Blood:同一性移植后用环磷酰胺和匹配非血缘供体移植两种移植方案的优劣

研究人员调查了192位接受同一性移植和1982位接受8/8 HLA匹配的非血缘供体移植的成年急性髓性白血病(AML)患者。同一性移植患者使用一种钙调磷酸酶抑制剂(CNI)—麦考酚脂,移植后使用环磷酰胺预防移植物抗宿主病(GVHD);其中的104个患者接受清髓处理,其余88位降低预处理方案强度。匹配非血缘供体移植给麦考酚脂或甲氨蝶呤预防GVHD;其中1245位患者接受清髓处理,其余737位

JAMA:骨髓移植或对重型镰状细胞病人有益

据发表在《美国医学会杂志》上的一则研究显示,应用某种较低强度的骨髓移植法在30名重症镰状细胞病的患者(16-65岁)中显示了有希望的结果。清髓性(使用高剂量的化疗或放疗)异基因造血干细胞移植(HSCT;即从另一个人那里接受造血干细胞“骨髓”)可治愈患重症镰状细胞病的孩子,但相关的毒性使得该疗法禁用于成年人。根据文章的背景资料,非清髓性预处理方案(即用较低剂量的化疗或放疗来进行骨髓准备以接受新的细胞

JEADV:因骨髓移植患上猕猴桃过敏!

一位46岁的中年男性接受了一次骨髓移植手术,供体是她的姐姐。有意思的是,这位姐姐有对猕猴桃过敏。手术过后,这位男性患者突然也对猕猴桃产生了过敏反应。基于这个机缘巧合,研究者们第一次证实过敏反应源于供体细胞。 尽管以前早有的报道,称接受骨髓移植的患者产生了新的过敏反应现象,但这是第一次能够证实该过敏反应的确是源于供体的骨髓细胞。这一发现能够为进一步探索过敏反应的产生以及治疗方法提供线索。

骨髓移植术-骨髓获取、正常解剖、手术指针、手术过程和手术预后(图片)

  骨髓是位于骨骼骨髓腔里柔软的脂肪组织,其功能是产生血细胞(红细胞、白细胞和血小板)。红细胞的功能是将为机体提供氧,白细胞的功能是抗感染,血小板的功能是凝血。  骨髓移植术适用于:  *红、白细胞缺陷性疾病,如再生障碍性贫血、白血病、淋巴瘤等。  *侵袭性癌肿的治疗,如化疗和放疗。  *遗传性疾病,如地中海贫血。  *免疫系统疾病,如先天性嗜中性粒细胞减少症、严重的复合免疫缺陷综合征等。